BR9811442A - Vacina à base de supositório vaginal para infecções urogenitais - Google Patents

Vacina à base de supositório vaginal para infecções urogenitais

Info

Publication number
BR9811442A
BR9811442A BR9811442-5A BR9811442A BR9811442A BR 9811442 A BR9811442 A BR 9811442A BR 9811442 A BR9811442 A BR 9811442A BR 9811442 A BR9811442 A BR 9811442A
Authority
BR
Brazil
Prior art keywords
suppository
based vaccine
urogenital
delivery system
orifice
Prior art date
Application number
BR9811442-5A
Other languages
English (en)
Inventor
Zsolt Istvan Hertelendy
Murray Weinger
Original Assignee
Protein Express
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protein Express filed Critical Protein Express
Publication of BR9811442A publication Critical patent/BR9811442A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"VACINA à BASE DE SUPOSITóRIO VAGINAL PARA INFECçõES UROGENITAIS". A presente invenção é dirigida a um sistema de fornecimento de vacina à base de supositório para imunização contra doença infecciosa urogenital em seres humanos e um método para tratar a mesma. Mais particularmente, a presente invenção é dirigida a um sistema de fornecimento de vacina à base de supositório para a profilaxia contra doenças infecciosas urogenitais, como infecções do trato urinário. O sistema de fornecimento de vacina à base de supositório compreende uma vacina compreendida de bactérias inativas que se originam de culturas de 8 a 14 cepas de bactérias uropatogênicas das espécies: Escherichia coli, Klebsiella pneumoniae, Proteus mírabilis, Proteus morganii, e Strepbococcus faecalis; e base de supositório de polietileno glicol; onde o supositório é adaptado para ser inserido em um orifício do corpo de um ser humano de modo a permitir que o supositório fique em contato com tecido do orifício do corpo para facilitar transferencia de material de supositório através do mesmo.
BR9811442-5A 1997-09-04 1998-09-03 Vacina à base de supositório vaginal para infecções urogenitais BR9811442A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/923,813 US6099853A (en) 1997-09-04 1997-09-04 Vaginal suppository vaccine for urogenital infections
PCT/US1998/018402 WO1999011286A1 (en) 1997-09-04 1998-09-03 Vaginal suppository vaccine for urogenital infections

Publications (1)

Publication Number Publication Date
BR9811442A true BR9811442A (pt) 2002-01-15

Family

ID=25449300

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811442-5A BR9811442A (pt) 1997-09-04 1998-09-03 Vacina à base de supositório vaginal para infecções urogenitais

Country Status (10)

Country Link
US (1) US6099853A (pt)
EP (1) EP1009428A1 (pt)
JP (1) JP2001514233A (pt)
CN (1) CN1195545C (pt)
AU (1) AU9220598A (pt)
BR (1) BR9811442A (pt)
CA (1) CA2302505A1 (pt)
PL (1) PL339075A1 (pt)
RU (1) RU2224542C2 (pt)
WO (1) WO1999011286A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
EP1303256B1 (en) * 2000-06-09 2009-01-07 Baylor College of Medicine The combination of antimicrobial agents and bacterial interference to coat medical devices
EP1521573B1 (en) * 2002-07-15 2008-01-02 Alcon, Inc. Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
ES2528669T3 (es) 2003-04-08 2015-02-11 Progenics Pharmaceuticals, Inc. Formulaciones farmacéuticas que contienen metilnaltrexona
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
PT2139890E (pt) 2007-03-29 2014-09-03 Wyeth Llc Antagonistas do receptor opióide periférico e respectivas utilizações
MX2009010550A (es) 2007-03-29 2009-12-14 Progenics Pharm Inc Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
PE20090700A1 (es) 2007-03-29 2009-07-13 Progenics Pharm Inc Compuestos heterociclicos como antagonistas del receptor opioide periferico
US7923001B2 (en) * 2007-09-07 2011-04-12 The Regents Of The University Of Michigan Compositions and methods for diagnosing and treating urinary tract infections
WO2009099411A1 (en) 2008-02-06 2009-08-13 Progenics Pharmaceuticals, Inc. Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
WO2013136185A2 (en) 2012-03-13 2013-09-19 Becton Dickinson France Method of manufacture for a miniaturized drug delivery device
US9694039B2 (en) * 2013-06-05 2017-07-04 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880991A (en) * 1969-03-24 1975-04-29 Brook David E Polymeric article for dispensing drugs
CH664497A5 (de) * 1984-08-31 1988-03-15 Solco Basel Ag Vakzine zur behandlung der harnwegsinfektionen.
US4939284A (en) * 1985-11-04 1990-07-03 The Procter & Gamble Company Process for the manufacture of tetraalkyl ethenylidenebisphosphonate esters
US4820698A (en) * 1985-11-04 1989-04-11 The Procter & Gamble Company Antimicrobial agents and process for their manufacture
US5364879A (en) * 1988-06-24 1994-11-15 Cliveden Ltd. Medical uses of trioxolane and diperoxide compounds
US5270344A (en) * 1988-06-24 1993-12-14 Stephen Herman Method of treating a systemic disorder using trioxolane and diperoxide compounds
US5057520A (en) * 1989-03-24 1991-10-15 Abbott Laboratories 7-(peptidylpyrolidinyl)naphthyridine antibacterial compounds
US5057523A (en) * 1988-09-22 1991-10-15 Abbott Laboratories Dipeptide quinolone derivatives

Also Published As

Publication number Publication date
CN1195545C (zh) 2005-04-06
US6099853A (en) 2000-08-08
PL339075A1 (en) 2000-12-04
EP1009428A1 (en) 2000-06-21
CA2302505A1 (en) 1999-03-11
AU9220598A (en) 1999-03-22
JP2001514233A (ja) 2001-09-11
RU2224542C2 (ru) 2004-02-27
WO1999011286A1 (en) 1999-03-11
CN1278735A (zh) 2001-01-03

Similar Documents

Publication Publication Date Title
BR9811442A (pt) Vacina à base de supositório vaginal para infecções urogenitais
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
BR0013780A (pt) Processo de melhoramento da pele e da pelagem de animais de estimação
DE69915458D1 (de) Dextran formulierungen zur behandlung entzündlicher gelenkerkrankungen
KR20100015767A (ko) 감염성 피부 및 점막 질환 치료약
TW200602068A (en) Antidiarrheal agent for livestock and poultry
RU2000108461A (ru) Вакцина против урогенитальных инфекций на основе вагинального суппозитория
MX7573E (es) Procedimiento para preparar una vacuna antibacteriana para el tratamiento profilactico y curativo de infecciones del tracto urinario en humanos
JP2001514233A5 (pt)
Österlund et al. Wound infection caused by Staphylococcus hyicus subspecies hyicus after a donkey bite
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
AU2001295722A1 (en) Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin
AR013480A1 (es) 9a-azalidas como agentes antimicrobicos veterinarios
WO2000016786A3 (en) Oxihumic acid and its use in the treatment of various conditions
BR0114104A (pt) Combinações microbianas óticas para tratamento de animais com membrana do tìmpano rompida
EP1183034B1 (en) Modulators of methylation for control of bacterial virulence
GB9806029D0 (en) 8a-Azalides as veterinary antimicrobial agents
BR0109034A (pt) Sistema de entrega de vacina baseado em supositório, e método para evitar doença urogenital ou anorretal em humanos ou animais
Burgess Chronic tenosynovitis caused by Actinobacillus actinomycetemcomitans
Raja et al. Therapeutic management of vaginitis in a mare
Santiago Slow progress on HIV vaccines
UA49889C2 (uk) Антибактеріальний препарат "бороцин"
Kroll et al. Lack of interference between three oral attenuated bacterial swine vaccines
BG49408A1 (en) Medicationad premix
Raja et al. THERAPEUTIC MANAGEMENT OF....

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.